[1]
K. Joshi, A. K. KC, R. K. Rijal, S. K. Rai, G. Lammichane, and R. D. Yadav, “Compliance and Visual Outcome Of “Treat-And-Extend” Versus ‘Pro Re Nata’Dosing of Intravitreal Bevacizumab in Wet Age-Related Macular Degeneration – A Perspective From a Developing Country”, Birat J. Health Sci., vol. 5, no. 1, pp. 921–926, Jun. 2020, doi: 10.3126/bjhs.v5i1.29614.